Continuous SEC was shown to increase productivity with the same product quality and yield.
Martin Glenz
Advertisement
Martin Glenz is principal scientist at Pall GmbH.
Articles by Martin Glenz
Advertisement
Latest Updated Articles
Continuous Preparative SEC for Purification of “Difficult-to-Manufacture” Proteins–A Feasibility StudyPublished: November 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
2
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
3
Establishing Risk Assessments for AI in Bio-Manufacturing
4
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
5
